
No differentiation or complex induction required. Ready for immediate use upon delivery, cutting culture time and resources.
Self-assembled 3D tissue with multiple native cell types to mimic physiological microenvironments.
Captures tissue-specific activities and phenotypic responses for reproducible toxicity testing.
Batch-consistent morphology, markers and function; well-controlled organoid size and structure.







Physiologically relevant and functionally validated organoids for drug toxicity assessment.

Essential reagents and consumables for reliable 3D organoid culture and maintenance.
Integrated human iPSC-derived cardiac organoids with MEA technology for reliable, real-time cardiotoxicity assessment in preclinical drug development.
Learn More